Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Carotid revascularization · Florida | Carotid revascularization · Texas | |
|---|---|---|
| Surgeons, 2024 | 67 | 54 |
| Medicare fee-for-service cases | 3,226 | 3,080 |
| Growth since 2019 (Medicare FFS) | −2.7%/yr | −4.9%/yr |
| Forecast cases (Medicare FFS) | 3,330 in 2030 | 3,370 in 2030 |
| Forecast growth | +0.5%/yr to 2030 | +1.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.4 | 1.4 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 48 | 57 |
| Top 10 surgeons' share | 29% | 35% |
| Surgeons growing | 5 | 3 |
| New since the base year | 5 | 5 |
| Likely to stop billing it | 33 by 2026 | 18 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $2,907 | $4,764 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.